For this reason, counseling and screening for BMPR2 mutations are often recommended not only for individuals with idiopathic PAH (IPAH) but also in sporadic and induced-by-anorexigens forms, as well as those with a family history of PAH. Here, BMPR2 is linked to pulmonary arterial hypertension.